Suppr超能文献

纳洛酮索赔与独立药店和连锁药店比例之间的关联:美国纳洛酮索赔的纵向分析。

The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States.

出版信息

J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102093. doi: 10.1016/j.japh.2024.102093. Epub 2024 Apr 10.

Abstract

BACKGROUND

Expanding access to naloxone through pharmacies is an important policy goal. Our objective was to characterize national county-level naloxone dispensing of chain versus independent pharmacies.

METHODS

The primary exposure in our longitudinal analysis was the proportion of chain pharmacies in a county, identified through the U.S. Department of Homeland Security 2010 Infrastructure Foundation-Level Data. We defined counties as having "higher proportion" of chain pharmacies if at least 50% of pharmacies were large national chains. The primary outcome was quarter-year (2016Q1-2019Q2) rate of pharmacy naloxone claims per 100,000 persons from Symphony Health at the county level. We compared the naloxone dispensing rate between county types using 2-sample t tests. We estimated the association between county-level chain pharmacy proportion and rate of naloxone claims using a linear model with year-quarter fixed effects.

RESULTS

Nearly one-third of counties (n = 946) were higher proportion. Higher proportion counties had a significantly higher rate of naloxone claims across the study period, in 4 of 6 urban-rural classifications, and in counties with and without naloxone access laws (NALs). The linear model confirmed that higher proportion counties had a significantly higher rate of naloxone claims, adjusting for urban-rural designation, income, population characteristics, opioid mortality rate, coprescribing laws, and NALs.

CONCLUSION

In this national study, we found an association between naloxone dispensing rates and the county-level proportion of chain (vs. independent) pharmacies. Incentivizing naloxone dispensing through educational, regulatory, or legal efforts may improve naloxone availability and dispensing rates-particularly in counties with proportionately high numbers of independent pharmacies.

摘要

背景

通过药店扩大纳洛酮的获取途径是一个重要的政策目标。我们的目标是描述全国县级连锁药店和独立药店的纳洛酮配药情况。

方法

在我们的纵向分析中,主要暴露因素是一个县的连锁药店比例,通过美国国土安全部 2010 年基础设施基础数据确定。我们将至少 50%的药店为大型全国连锁店的县定义为“连锁药店比例较高”。主要结果是每个县每季度(2016 年第一季度至 2019 年第二季度)从 Symphony Health 获得的药店纳洛酮配药率,以每 10 万人为单位。我们使用 2 样本 t 检验比较了不同县类型的纳洛酮配药率。我们使用具有年季度固定效应的线性模型,估计了县级连锁药店比例与纳洛酮配药率之间的关联。

结果

近三分之一的县(n=946)属于连锁药店比例较高的县。在整个研究期间,在 6 个城乡分类中的 4 个,以及在有和没有纳洛酮获取法(NAL)的县中,连锁药店比例较高的县的纳洛酮配药率都显著较高。线性模型证实,在调整了城乡指定、收入、人口特征、阿片类药物死亡率、共同处方法和 NAL 后,连锁药店比例较高的县的纳洛酮配药率显著较高。

结论

在这项全国性研究中,我们发现纳洛酮配药率与县级连锁(与独立)药店比例之间存在关联。通过教育、监管或法律手段激励纳洛酮配药,可能会提高纳洛酮的可及性和配药率,特别是在独立药店比例较高的县。

相似文献

3
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review.
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1725-1740. doi: 10.1016/j.japh.2022.07.008. Epub 2022 Jul 31.
4
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
5
Interventions to reduce non-prescription antimicrobial sales in community pharmacies.
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD013722. doi: 10.1002/14651858.CD013722.pub2.
6
Pharmacists' naloxone services beyond community pharmacy settings: A systematic review.
Res Social Adm Pharm. 2023 Feb;19(2):243-265. doi: 10.1016/j.sapharm.2022.09.002. Epub 2022 Sep 15.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Do heroin overdose patients require observation after receiving naloxone?
Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16.
9
Opioid antagonists with minimal sedation for opioid withdrawal.
Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.

引用本文的文献

1
Transforming Opioid Overdose Prevention in the United States: Leveraging FDA's Narcan Approval to Foster a Culture of Health.
Risk Manag Healthc Policy. 2025 Jun 14;18:1935-1946. doi: 10.2147/RMHP.S521720. eCollection 2025.
2
Naloxone training programs in corporately-owned versus independently-owned Alabama community pharmacies: A pilot cross-sectional survey.
Drug Alcohol Depend Rep. 2025 Mar 28;15:100326. doi: 10.1016/j.dadr.2025.100326. eCollection 2025 Jun.

本文引用的文献

2
A Systematic Review of Independent and Chain Pharmacies Effects on Medication Adherence.
Pharmacy (Basel). 2022 Sep 29;10(5):124. doi: 10.3390/pharmacy10050124.
3
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis.
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1816-1822.e2. doi: 10.1016/j.japh.2022.07.003. Epub 2022 Jul 15.
4
Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012-2019.
Am J Prev Med. 2021 Dec;61(6):e289-e295. doi: 10.1016/j.amepre.2021.05.042. Epub 2021 Oct 18.
5
Analysis of naloxone access and primary medication nonadherence in a community pharmacy setting.
J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):49-54. doi: 10.1016/j.japh.2021.10.011. Epub 2021 Oct 21.
6
State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.
Drug Alcohol Depend. 2021 Oct 1;227:109012. doi: 10.1016/j.drugalcdep.2021.109012. Epub 2021 Aug 28.
7
Naloxone availability in independent community pharmacies in Georgia, 2019.
Subst Abuse Treat Prev Policy. 2021 Aug 21;16(1):63. doi: 10.1186/s13011-021-00402-w.
8
Implications of county-level variation in U.S. opioid distribution.
Drug Alcohol Depend. 2021 Feb 1;219:108501. doi: 10.1016/j.drugalcdep.2020.108501. Epub 2021 Jan 3.
9
Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability.
West J Emerg Med. 2020 Aug 24;21(5):1188-1194. doi: 10.5811/westjem.7.2020.47252.
10
Availability of Naloxone at Rural Georgia Pharmacies, 2019.
JAMA Netw Open. 2020 Feb 5;3(2):e1921227. doi: 10.1001/jamanetworkopen.2019.21227.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验